Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Urine NMR-based TB metabolic fingerprinting for the diagnosis of TB in children

  • Izquierdo García, José Luis
  • Ruiz-Cabello Osuna, Jesús
Tuberculosis (TB) is a major cause of morbidity and mortality in children, and early diagnosis and treatment are crucial to reduce long-term morbidity and mortality. In this study, we explore whether urine nuclear magnetic resonance (NMR)-based metabolomics could be used to identify differences in the metabolic response of children with different diagnostic certainty of TB. We included 62 children with signs and symptoms of TB and 55 apparently healthy children. Six of the children with presumptive TB had bacteriologically confirmed TB, 52 children with unconfirmed TB, and 4 children with unlikely TB. Urine metabolic fingerprints were identified using high- and low-field proton NMR platforms and assessed with pattern recognition techniques such as principal components analysis and partial least squares discriminant analysis. We observed differences in the metabolic fingerprint of children with bacteriologically confirmed and unconfirmed TB compared to children with unlikely TB (p= 0.041 and p= 0.013, respectively). Moreover, children with unconfirmed TB with X-rays compatible with TB showed differences in the metabolic fingerprint compared to children with non-pathological X-rays (p= 0.009). Differences in the metabolic fingerprint in children with different diagnostic certainty of TB could contribute to a more accurate characterisation of TB in the paediatric population. The use of metabolomics could be useful to improve the prediction of TB progression and diagnosis in children.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2

  • Safont Gonzalez, Guillem|||0000-0001-8174-4279
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Smalchuk, Daria
  • Stojanovic, Zonan
  • Marín, Alicia|||0000-0002-9358-2120
  • Lacoma, Alicia|||0000-0002-2049-3872
  • Pérez-Cano, Cristina
  • López-Martínez, Anabel
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Solis, Alan Jhunior
  • Arméstar, Fernando|||0000-0002-6374-1418
  • Matllo, Joan
  • Díaz-Fernández, Sergio
  • Romero, Iris
  • Casas, Irma|||0000-0002-5902-5777
  • Strecker, Kevin
  • Preyer, Rosemarie
  • Rosell Gratacos, Antoni|||0000-0003-0877-7191
  • Latorre, Irene|||0000-0001-8159-2455
  • Domínguez, José|||0000-0001-7888-0309
The study of specific T-cell responses against SARS-CoV-2 is important for understanding long-term immunity and infection management. The aim of this study was to assess the dual IFN-γ and IL-2 detection, using a SARS-CoV-2 specific fluorescence ELISPOT, in patients undergoing acute disease, during convalescence, and after vaccination. We also evaluated humoral response and compared with T-cells with the aim of correlating both types of responses, and increase the number of specific response detection. Blood samples were drawn from acute COVID-19 patients and convalescent individuals classified according to disease severity; and from unvaccinated and vaccinated uninfected individuals. IgGs against Spike and nucleocapsid, IgMs against nucleocapsid, and neutralizing antibodies were also analyzed. Our results show that IFN-γ in combination with IL-2 increases response detection in acute and convalescent individuals (p = 0.023). In addition, IFN-γ detection can be a useful biomarker for monitoring severe acute patients, as our results indicate that those individuals with a poor outcome have lower levels of this cytokine. In some cases, the lack of cellular immunity is compensated by antibodies, confirming the role of both types of immune responses in infection, and confirming that their dual detection can increase the number of specific response detections. In summary, IFN-γ/IL-2 dual detection is promising for characterizing and assessing the immunization status, and helping in the patient management.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development and Evaluation of an NTM-IGRA to Guide Pediatric Lymphadenitis Diagnosis

  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Latorre, Irene|||0000-0001-8159-2455
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • Martínez-Planas, Aina
  • Minguell Domingo, Laura
  • Vallmanya, Teresa
  • Méndez Hernández, Maria|||0000-0001-5697-2763
  • Soriano-Arandes, Antoni|||0000-0001-9613-7228
  • Baquero-Artigao, Fernando|||0000-0002-6903-3826
  • Rodríguez-Molino, Paula
  • Guillén-Martín, Sara
  • Toro Rueda, Carlos
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • Sabriá, Josefina
  • Santos, José Ramón|||0000-0002-0886-7114
  • Puig, Jordi|||0000-0002-4075-0346
  • Domínguez-Álvarez, Marisol
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Altet, Neus
  • Galea, Yolanda
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • García-García, Esther
  • Bach Griera, Marc|||0000-0001-9845-7225
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Julián, Esther|||0000-0002-6558-3978
  • Torrelles, Jordi B.|||0000-0001-7702-5941
  • Rodrigo Gonzalo de Líria, Carlos|||0000-0003-1140-2585
  • Domínguez, José|||0000-0001-7888-0309
Background: Diagnosis of nontuberculous mycobacteria (NTM) infections remains a challenge. In this study, we describe the evaluation of an immunological NTM-interferon (IFN)-γ release assay (IGRA) that we developed using glycopeptidolipids (GPLs) as NTM-specific antigens. Methods: We tested the NTM-IGRA in 99 samples from pediatric patients. Seventy-five were patients with lymphadenitis: 25 were NTM confirmed, 45 were of unknown etiology but compatible with mycobacterial infection and 5 had lymphadenitis caused by an etiologic agent other than NTM. The remaining 24 samples were from control individuals without lymphadenitis (latently infected with M.Tuberculosis, uninfected controls and active tuberculosis patients). Peripheral blood mononuclear cells were stimulated overnight with GPLs. Detection of IFN-γ producing cells was evaluated by enzyme-linked immunospot assay. Results: NTM culture-confirmed lymphadenitis patient samples had a significantly higher response to GPLs than the patients with lymphadenitis of unknown etiology but compatible with mycobacterial infection (P < 0.001) and lymphadenitis not caused by NTM (P < 0.01). We analyzed the response against GPLs in samples from unknown etiology lymphadenitis but compatible with mycobacterial infection cases according to the tuberculin skin test (TST) response, and although not statistically significant, those with a TST ≥5 mm had a higher response to GPLs when compared with the TST <5 mm group. Conclusions: Stimulation with GPLs yielded promising results in detecting NTM infection in pediatric patients with lymphadenitis. Our results indicate that the test could be useful to guide the diagnosis of pediatric lymphadenitis. This new NTM-IGRA could improve the clinical handling of NTM-infected patients and avoid unnecessary misdiagnosis and treatments.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

MptpB Inhibitor Improves the Action of Antibiotics against Mycobacterium tuberculosis and Nontuberculous Mycobacterium avium Infections

  • Rodríguez-Fernández, Pablo|||0000-0003-1273-0548
  • Botella, Laure
  • Cavet, Jennifer S.
  • Domínguez, José|||0000-0001-7888-0309
  • Gutierrez, Maximiliano G.|||0000-0003-3199-0337
  • Suckling, Colin J.
  • Scott, Fraser J.|||0000-0003-0229-3698
  • Tabernero, Lydia|||0000-0001-8867-455X
Treatment of Mycobacterium tuberculosis and Mycobacterium avium infections requires multiple drugs for long time periods. Mycobacterium protein-tyrosine-phosphatase B (MptpB) is a key M. tuberculosis virulence factor that subverts host antimicrobial activity to promote intracellular survival. Inhibition of MptpB reduces the infection burden in vivo and offers new opportunities to improve current treatments. Here, we demonstrate that M. avium produces an MptpB orthologue and that the MptpB inhibitor C13 reduces the M. avium infection burden in macrophages. Combining C13 with the antibiotics rifampicin or bedaquiline showed an additive effect, reducing intracellular infection of both M. tuberculosis and M. avium by 50%, compared to monotreatment with antibiotics alone. This additive effect was not observed with pretomanid. Combining C13 with the minor groove-binding compounds S-MGB-362 and S-MGB-363 also reduced the M. tuberculosis intracellular burden. Similar additive effects of C13 and antibiotics were confirmed in vivo using Galleria mellonella infections. We demonstrate that the reduced mycobacterial burden in macrophages observed with C13 treatments is due to the increased trafficking to lysosomes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Benchtop NMR urine metabolomics for diagnosing pulmonary tuberculosis

  • Comella-del-Barrio, Patricia|||0000-0002-2433-9864
  • Rodríguez, Ignacio
  • Bimba, John|||0000-0001-7847-4271
  • Osazuwa, Okoedoh
  • Alaran, Ramota
  • Alonso, Pilar
  • Blasco Iturri, Zuriñe
  • Miguel-Coello, Ana B
  • Cuevas, Luis E.|||0000-0002-6581-0587
  • Ruiz-Cabello, Jesús|||0000-0001-8681-5056
  • Izquierdo-Garcia, José Luis
  • Domínguez, José|||0000-0001-7888-0309
Tuberculosis (TB) remains a major global health issue, especially in resource-limited settings, where rapid and accurate diagnosis is critical yet often lacking. Nuclear magnetic resonance (NMR)-based metabolomics has emerged as a promising tool for identifying disease-specific biomarkers. This study assessed the diagnostic potential of urinary metabolomics using high-resolution (HR-)NMR and benchtop NMR (bNMR) in Nigerian adults with presumed pulmonary TB, including individuals with and without HIV. Urine samples were analysed by HR-NMR and bNMR. Multivariate analysis was used to develop classification models based on confirmed TB status. Key discriminant metabolites were identified. In HIV-negative individuals, HR-NMR achieved 84% sensitivity and 86% specificity, while bNMR reached 83% and 84%, respectively. In people living with HIV, HR-NMR reached 75% sensitivity and 70% specificity; bNMR achieved 90% and 46%. Both models met or exceeded WHO sensitivity criteria for non-sputum-based TB diagnostics. Thirteen discriminatory metabolites were identified, with eight consistent with previous studies. These findings suggest common metabolic signatures of TB, regardless of HIV status. Urinary NMR-based metabolomics shows strong potential for TB diagnosis in high TB/HIV burden settings. HR-NMR provides excellent accuracy, while bNMR offers a cost-effective alternative. Further studies are needed to validate and optimise this approach for clinical use.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Urine NMR-based TB metabolic fingerprinting for the diagnosis of TB in children

  • Comella-del-Barrio, Patricia
  • Izquierdo-García, José Luis
  • Gautier, Jacqueline
  • Coute Doresca, Mariette Jean
  • Campos Olivas, Ramón
  • Santiveri, Clara M.
  • Muriel Moreno, Beatriz
  • Prat, Cristina
  • Abellana Sangrà, Rosa Mari
  • Pérez-Porcuna, Tomàs M.
  • Cuevas, Luis E.
  • Ruiz Cabello, Jesús
  • Dominguez, Jose
Tuberculosis (TB) is a major cause of morbidity and mortality in children, and early diagnosis and treatment are crucial to reduce long-term morbidity and mortality. In this study, we explore whether urine nuclear magnetic resonance (NMR)-based metabolomics could be used to identify differences in the metabolic response of children with different diagnostic certainty of TB. We included 62 children with signs and symptoms of TB and 55 apparently healthy children. Six of the children with presumptive TB had bacteriologically confirmed TB, 52 children with unconfirmed TB, and 4 children with unlikely TB. Urine metabolic fingerprints were identified using high- and low-field proton NMR platforms and assessed with pattern recognition techniques such as principal components analysis and partial least squares discriminant analysis. We observed differences in the metabolic fingerprint of children with bacteriologically confirmed and unconfirmed TB compared to children with unlikely TB (p = 0.041 and p = 0.013, respectively). Moreover, children with unconfirmed TB with X-rays compatible with TB showed differences in the metabolic fingerprint compared to children with non-pathological X-rays (p = 0.009). Differences in the metabolic fingerprint in children with different diagnostic certainty of TB could contribute to a more accurate characterisation of TB in the paediatric population. The use of metabolomics could be useful to improve the prediction of TB progression and diagnosis in children.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Further Advances in Atrial Fibrillation Research: A Metabolomic Perspective

  • Arbeloa-Gómez, Laura
  • Álvarez-Vidal, Jaime
  • Izquierdo-García, Jose Luis
Atrial fibrillation involves an important type of heart arrhythmia caused by a lack of control in the electrical signals that arrive in the heart, produce an irregular auricular contraction, and induce blood clotting, which finally can lead to stroke. Atrial fibrillation presents some specific characteristics, but it has been treated and prevented using conventional methods similar to those applied to other cardiovascular diseases. However, due to the influence of this pathology on the mortality caused by cerebrovascular accidents, further studies on the molecular mechanism of atrial fibrillation are required. Our aim here is provide a compressive review of the use of metabolomics on this condition, from the study of the metabolic profile of plasma to the development of animal models. In summary, most of the reported studies highlighted alterations in the energetic pathways related to the development of the condition., This research was supported by grants: (i) PID2019-10656RJ-I00 from the Spanish Ministry of Science and Innovation; (ii) B2017/BMD3875 from the Comunidad de Madrid, Madrid, Spain; and (iii) the European Union’s Horizon 2020 Research and Innovation Program, under the Marie Skłodowska-Curie grant agreement no. 823854 (INNOVA4TB)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Urine NMR-based TB metabolic fingerprinting for the diagnosis of TB in children

  • Comella-del-Barrio, Patricia
  • Izquierdo-García, José Luis
  • Gautier, Jacqueline
  • Coute Doresca, Mariette Jean
  • Campos Olivas, Ramón
  • Santiveri, Clara M.
  • Muriel Moreno, Beatriz
  • Prat, Cristina
  • Abellana Sangrà, Rosa Mari
  • Pérez-Porcuna, Tomàs M.
  • Cuevas, Luis E.
  • Ruiz Cabello, Jesús
  • Dominguez, Jose
Tuberculosis (TB) is a major cause of morbidity and mortality in children, and early diagnosis and treatment are crucial to reduce long-term morbidity and mortality. In this study, we explore whether urine nuclear magnetic resonance (NMR)-based metabolomics could be used to identify differences in the metabolic response of children with different diagnostic certainty of TB. We included 62 children with signs and symptoms of TB and 55 apparently healthy children. Six of the children with presumptive TB had bacteriologically confirmed TB, 52 children with unconfirmed TB, and 4 children with unlikely TB. Urine metabolic fingerprints were identified using high- and low-field proton NMR platforms and assessed with pattern recognition techniques such as principal components analysis and partial least squares discriminant analysis. We observed differences in the metabolic fingerprint of children with bacteriologically confirmed and unconfirmed TB compared to children with unlikely TB (p = 0.041 and p = 0.013, respectively). Moreover, children with unconfirmed TB with X-rays compatible with TB showed differences in the metabolic fingerprint compared to children with non-pathological X-rays (p = 0.009). Differences in the metabolic fingerprint in children with different diagnostic certainty of TB could contribute to a more accurate characterisation of TB in the paediatric population. The use of metabolomics could be useful to improve the prediction of TB progression and diagnosis in children.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment

  • Díaz-Fernández, Sergio
  • Villar-Hernández, Raquel
  • Stojanovic, Zoran
  • Fernández, Marco
  • De Souza Galvao, Maria Luiza
  • Tolosa, Guillermo
  • Jiménez Fuentes, Maria Angeles
  • Sánchez Montalvá, Adrián
Mycobacterium tuberculosis; T-cells; Immune response, Tuberculosis micobacteriana; Células T; Respuesta inmune, Tuberculosi micobacteriana; Cèl·lules T; Resposta immune, Background: Current blood-based diagnostic tools for TB are insufficient to properly characterize the distinct stages of TB, from the latent infection (LTBI) to its active form (aTB); nor can they assess treatment efficacy. Several immune cell biomarkers have been proposed as potential candidates for the development of improved diagnostic tools. Objective: To compare the capacity of CD27, HLA-DR, CD38 and Ki-67 markers to characterize LTBI, active TB and patients who ended treatment and resolved TB. Methods: Blood was collected from 45 patients defined according to clinical and microbiological criteria as: LTBI, aTB with less than 1 month of treatment and aTB after completing treatment. Peripheral blood mononuclear cells were stimulated with ESAT-6/CFP-10 or PPD antigens and acquired for flow cytometry after labelling with conjugated antibodies against CD3, CD4, CD8, CD27, IFN-γ, TNF-α, CD38, HLA-DR, and Ki-67. Conventional and multiparametric analyses were done with FlowJo and OMIQ, respectively. Results: The expression of CD27, CD38, HLA-DR and Ki-67 markers was analyzed in CD4+ T-cells producing IFN-γ and/or TNF-α cytokines after ESAT-6/CFP-10 or PPD stimulation. Within antigen-responsive CD4+ T-cells, CD27− and CD38+ (ESAT-6/CFP-10-specific), and HLA-DR+ and Ki-67+ (PPD- and ESAT-6/CFP-10-specific) populations were significantly increased in aTB compared to LTBI. Ki-67 demonstrated the best discriminative performance as evaluated by ROC analyses (AUC > 0.9 after PPD stimulation). Data also points to a significant change in the expression of CD38 (ESAT-6/CFP-10-specific) and Ki-67 (PPD- and ESAT-6/CFP-10-specific) after ending the anti-TB treatment regimen. Furthermore, ratio based on the CD27 median fluorescence intensity in CD4+ T-cells over Mtb-specific CD4+ T-cells showed a positive association with aTB over LTBI (ESAT-6/CFP-10-specific). Additionally, multiparametric FlowSOM analyses revealed an increase in CD27 cell clusters and a decrease in HLA-DR cell clusters within Mtb-specific populations after the end of treatment. Conclusion: Our study independently confirms that CD27−, CD38+, HLA-DR+ and Ki-67+ populations on Mtb-specific CD4+ T-cells are increased during active TB disease. Multiparametric analyses unbiasedly identify clusters based on CD27 or HLA-DR whose abundance can be related to treatment efficacy. Further studies are necessary to pinpoint the convergence between conventional and multiparametric approaches., This research was supported by a grant from the Instituto de Salud Carlos III (PI18/00411, PI19/01408 and CP20/00070), integrated in the Plan Nacional de I + D + I and cofunded by the ISCIII Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER); a grant from the Sociedad Española de Neumología y Cirugía Torácica (project 25/2016; SEPAR; Barcelona, Spain); and from the European Union’s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement no. 823854 (INNOVA4TB). JD and IL are researchers from the Miguel Servet programme. AS-M is supported by a Juan Rodés (JR18/00022) postdoctoral fellowship from ISCIII.
Archivo Digital UPM
Publication Artículo científico (JournalArticle)

Chest X-Ray–Based Telemedicine Platform for Pediatric Tuberculosis Diagnosis in Low-Resource Settings: Development and Validation Study

  • Gómez Valverde, Juan José|||0000-0002-5073-5908
  • Sánchez Jacob, Ramón|||0000-0003-0100-3230
  • Ribó, José Luis|||0009-0002-4045-9943
  • Schaaf, Hendrik Simon|||0000-0001-5755-4133
  • García Delgado, Lara|||0000-0001-8325-7730
  • Hernaz Lobo, Alicia|||0000-0002-9560-9104
  • Capellán Martín, Daniel|||0000-0002-9743-0845
  • Lancharro Zapata, Ángel|||0000-0001-9439-1951
  • Augusto, Orvalho|||0000-0002-0005-3968
  • Garcia Basteiro, Alberto L.|||0000-0002-2038-5505
  • Santiago García, Begoña|||0000-0002-4125-0423
  • López Varela, Elisa|||0000-0002-6725-5687
  • Ledesma Carbayo, María Jesús|||0000-0001-6846-3923
Archivo Digital UPM
Publication Contribución de congreso (ConferenceOutput)

A Lightweight, Rapid and Efficient Deep Convolutional Network for Chest X-Ray Tuberculosis Detection

  • Gómez Valverde, Juan José|||0000-0002-5073-5908
  • Bermejo Peláez, David|||0000-0002-0181-3957
  • Capellán Martín, Daniel|||0000-0002-9743-0845
  • Ledesma Carbayo, Maria Jesus|||0000-0001-6846-3923
Archivo Digital UPM
Publication Contribución de congreso (ConferenceOutput)

Zero-Shot Pediatric Tuberculosis Detection in Chest X-Rays Using Self-Supervised Learning

  • Capellán Martín, Daniel|||0000-0002-9743-0845
  • Parida, Abhijeet|||0000-0002-4978-0576
  • Gómez Valverde, Juan José|||0000-0002-5073-5908
  • Sánchez Jacob, Ramón|||0000-0003-0100-3230
  • Roshanitabrizi, Pooneh|||0000-0002-8853-2786
  • Linguraru, Marius George|||0000-0001-6175-8665
  • Ledesma Carbayo, María Jesús|||0000-0001-6846-3923
  • Anwar, Syed Muhammad
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fujifilm silvamp tb-lam for the diagnosis of tuberculosis in nigerian adults

  • Comella-del-Barrio, Patricia|||0000-0002-2433-9864
  • Bimba, John|||0000-0001-7847-4271
  • Adelakun, Ramota
  • Kontogianni, Konstantina
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Osazuwa, Okoedoh
  • Creswell, Jacob|||0000-0002-4885-940X
  • Cuevas, Luis E.|||0000-0002-6581-0587
  • Domínguez, José|||0000-0001-7888-0309
There is a need for diagnostics for tuberculosis (TB) that are easy to use, able to screen non-sputum samples, and able to provide rapid results for the management of both immunocompromised and immunocompetent individuals. The Fujifilm SILVAMP TB LAM (FujiLAM) assay, a new non-sputum based point of need test for the diagnosis of TB, could potentially address most of these needs. We evaluated the performance of FujiLAM in HIV positive and HIV negative patients with presumptive TB attending three district hospitals in Nigeria. Consecutive patients were asked to provide urine samples on the spot, which were tested with FujiLAM. The results were compared against a positive culture and/or Xpert MTB/RIF as the reference standard. Forty-five patients had bacteriologically confirmed TB, and 159 had negative culture and Xpert MTB/RIF (no TB). The FujiLAM test was positive in 23 (sensitivity 65.7%, 95% CI = 48-80) HIV negative and seven (70%, 95% CI = 35-92) HIV positive patients with bacteriological confirmation of TB. FujiLAM was negative in 97 (specificity 99.0%, 95% CI = 94-100) HIV negative and 56 (93.3%, 95% CI = 83-98) HIV positive patients without TB. The FujiLAM test has good diagnostic accuracy for considering its application in both HIV positive and HIV negative patients with TB.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Molecular Detection of Mycobacterium tuberculosis in Oral Mucosa from Patients with Presumptive Tuberculosis

  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Ciobanu, Nelly
  • Hernandez, Marta
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Crudu, Valeriu|||0000-0001-5059-8002
  • Adams, Emily|||0000-0002-0816-2835
  • Codreanu, Alexandru
  • Sloan, Derek J.
  • Cuevas, Luis E.|||0000-0002-6581-0587
  • Domínguez, José|||0000-0001-7888-0309
Tuberculosis (TB) diagnosis is increasingly based on the detection of Mycobacterium tuberculosis complex (MTBC) DNA in sputum using molecular diagnostic tests as the first test for diagnosis. However, sputum can be difficult to obtain in children, patients without productive cough, and the elderly and approaches testing non-sputum samples are needed. We evaluated whether TB can be detected from the oral mucosa of patients with TB. Adults with presumptive TB were examined using culture, Xpert MTB/RIF, smear microscopy and X-Rays. Oral mucosa swabs collected on PrimeStore-MTM, stored at room temperature if tested within 30 days or at -20 °C if examined at a later time. RT-PCR was performed to detect M. tuberculosis DNA. Eighty patients had bacteriologically-confirmed TB, 34 had bacteriologically-negative TB (negative tests but abnormal X-rays) and 152 were considered not to have TB (not TB). Oral swabs RT-PCR were positive in 29/80 (36.3%) bacteriologically-confirmed, 9/34 (26.5%) bacteriologically-negative and 29/152 (19.1%) not TB. The yield varied among samples stored for less and more than 30 days (p = 0.013) from 61% (11/18) and 29% (18/62) among bacteriologically confirmed, and 30.8% (4/13) and 23.8% (5/21) among bacteriologically-negative participants. Among not TB patients, the specificity was 80.9% (123/152), being 78.3% (18/23) among samples stored less than 30 days and 81.4% (105/129) among samples stored for more than 30 days (p = 0.46). The detection of M. tuberculosis in oral mucosa samples is feasible, but storage conditions may affect the yield.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Diagnostic Performance of the Fujifilm SILVAMP TB-LAM in Children with Presumptive Tuberculosis

  • Comella-del-Barrio, Patricia|||0000-0002-2433-9864
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Gautier, Jacqueline
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Doresca, Mariette Jean Coute
  • Sallés-Mingels, Beatriz
  • Canales-Aliaga, Lydia
  • Narcisse, Margareth
  • Pérez-Porcuna, Tomás M.|||0000-0002-9951-7768
  • Creswell, Jacob|||0000-0002-4885-940X
  • Cuevas, Luis E.|||0000-0002-6581-0587
  • Domínguez, José|||0000-0001-7888-0309
Current diagnostics for tuberculosis (TB) only manage to confirm a small proportion of children with TB and require respiratory samples, which are difficult to obtain. There is a need for non-invasive biomarker-based tests as an alternative to sputum testing. Fujifilm SILVAMP TB lipoarabinomannan (FujiLAM), a lateral-flow test to detect lipoarabinomannan in urine, is a novel non-sputum-based point-of-care diagnostic reported to have increased sensitivity for the diagnosis of TB among human immunodeficiency virus (HIV)-infected adults. We evaluate the performance of FujiLAM in children with presumptive TB. Fifty-nine children attending a paediatric hospital in Haiti with compatible signs and symptoms of TB were examined using Xpert MTB/RIF, smear microscopy and X-rays, and classified according to the certainty of diagnosis into bacteriologically confirmed TB (n = 5), unconfirmed TB (bacteriologically negative, n = 50) and unlikely TB (n = 4). Healthy children (n = 20) were enrolled as controls. FujiLAM sensitivity and specificity were 60% and 95% among children with confirmed TB. FujiLAM's high specificity and its characteristics as a point-of-care indicate the test has a good potential for the diagnosis of TB in children.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Molecular and Cellular Mechanisms of M. tuberculosis and SARS-CoV-2 Infections-Unexpected Similarities of Pathogenesis and What to Expect from Co-Infection

  • Starshinova, Anna A.
  • Kudryavtsev, Igor
  • Malkova, Anna|||0000-0002-6008-1354
  • Zinchenko, Ulia|||0000-0002-6273-4304
  • Karev, Vadim
  • Kudlay, Dmitry|||0000-0003-1878-4467
  • Glushkova, Angela
  • Starshinova, Anastasiya Y.
  • Domínguez, José|||0000-0001-7888-0309
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Dovgalyk, Irina
  • Yablonskiy, Piotr
Tuberculosis is still an important medical and social problem. In recent years, great strides have been made in the fight against M. tuberculosis, especially in the Russian Federation. However, the emergence of a new coronavirus infection (COVID-19) has led to the long-term isolation of the population on the one hand and to the relevance of using personal protective equipment on the other. Our knowledge regarding SARS-CoV-2-induced inflammation and tissue destruction is rapidly expanding, while our understanding of the pathology of human pulmonary tuberculosis gained through more the 100 years of research is still limited. This paper reviews the main molecular and cellular differences and similarities caused by M. tuberculosis and SARS-CoV-2 infections, as well as their critical immunological and pathomorphological features. Immune suppression caused by the SARS-CoV-2 virus may result in certain difficulties in the diagnosis and treatment of tuberculosis. Furthermore, long-term lymphopenia, hyperinflammation, lung tissue injury and imbalance in CD4+ T cell subsets associated with COVID-19 could propagate M. tuberculosis infection and disease progression.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Measuring T-Cell Responses against SARS-CoV-2 Is of Utility for Disease and Vaccination Management

  • Safont Gonzalez, Guillem|||0000-0001-8174-4279
  • Latorre, Irene|||0000-0001-8159-2455
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Stojanovic, Zorac
  • Marín, Alicia|||0000-0002-9358-2120
  • Pérez-Cano, Cristina
  • Lacoma, Alicia|||0000-0002-2049-3872
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Solis, Alan Jhurior
  • Arméstar, Fernando|||0000-0002-6374-1418
  • Matllo, Joan
  • Díaz-Fernández, Sergio
  • Cendón Esteve, Arnau
  • Sokalchuk, Liliya
  • Tolosa, Guillermo
  • Casas, Irma|||0000-0002-5902-5777
  • Rosell Gratacos, Antoni|||0000-0003-0877-7191
  • Domínguez, José|||0000-0001-7888-0309
The measurement of specific T-cell responses can be a useful tool for COVID-19 diagnostics and clinical management. In this study, we evaluated the IFN-γ T-cell response against the main SARS-CoV-2 antigens (spike, nucleocapsid and membrane) in acute and convalescent individuals classified according to severity, and in vaccinated and unvaccinated controls. IgG against spike and nucleocapsid were also measured. Spike antigen triggered the highest number of T-cell responses. Acute patients showed a low percentage of positive responses when compared to convalescent (71.6% vs. 91.7%, respectively), but increased during hospitalization and with severity. Some convalescent patients showed an IFN-γ T-cell response more than 200 days after diagnosis. Only half of the vaccinated individuals displayed an IFN-γ T-cell response after the second dose. IgG response was found in a higher percentage of individuals compared to IFN-γ T-cell responses, and moderate correlations between both responses were seen. However, in some acute COVID-19 patients specific T-cell response was detected, but not IgG production. We found that the chances of an IFN-γ T-cell response against SARS-CoV-2 is low during acute phase, but may increase over time, and that only half of the vaccinated individuals had an IFN-γ T-cell response after the second dose.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of diesel exhaust particles on infections with Mycobacterium bovis BCG in in vitro human macrophages and an in vivo Galleria mellonella model

  • Rodríguez-Fernández, Pablo|||0000-0003-1273-0548
  • Romero i Andrada, Iris
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Latorre, Irene|||0000-0001-8159-2455
  • Lacoma, Alicia|||0000-0002-2049-3872
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Tabernero, Lydia|||0000-0001-8867-455X
  • Domínguez, José|||0000-0001-7888-0309
There are strong suggestions for a link between pulmonary tuberculosis (TB) and air quality. Diesel exhaust is one of the main contributors to pollution and it is reported to be able to modify susceptibility to lung infections. In this study we exposed THP-1 human macrophages and Mycobacterium bovis BCG to diesel exhaust particles (DEPs). High cytotoxicity and activation of apoptosis was found in THP-1 cells at 3 and 6 days, but no effect was found on the growth of M. bovis BCG. Infection of THP-1 cells exposed to a non-cytotoxic DEP concentration showed a limited capacity to engulf latex beads. However, M. bovis BCG infection of macrophages did not result in an increase in the bacterial burden, but it did result in an increase in the bacteria recovered from the extracellular media, suggesting a poor contention of M. bovis BCG. We also observed that DEP exposure limited the production of cytokines. Using the Galleria mellonella model of infection, we observed that larvae exposed to low levels of DEPs were less able to survive after infection with M. bovis BCG and had a higher internal bacterial load after 4 days of infection. Unraveling the links between air pollution and impairment of human antimycobacterial immunity is vital, because pollution is rapidly increasing in areas where TB incidence is extremely high.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment

  • Díaz-Fernández, Sergio
  • Villar-Hernández, Raquel
  • Stojanovic, Zoran
  • Fernández, Marco
  • De Souza Galvao, Maria Luiza
  • Tolosa, Guillermo
  • Jiménez Fuentes, Maria Angeles
  • Sánchez Montalvá, Adrián
Mycobacterium tuberculosis; T-cells; Immune response, Tuberculosis micobacteriana; Células T; Respuesta inmune, Tuberculosi micobacteriana; Cèl·lules T; Resposta immune, Background: Current blood-based diagnostic tools for TB are insufficient to properly characterize the distinct stages of TB, from the latent infection (LTBI) to its active form (aTB); nor can they assess treatment efficacy. Several immune cell biomarkers have been proposed as potential candidates for the development of improved diagnostic tools. Objective: To compare the capacity of CD27, HLA-DR, CD38 and Ki-67 markers to characterize LTBI, active TB and patients who ended treatment and resolved TB. Methods: Blood was collected from 45 patients defined according to clinical and microbiological criteria as: LTBI, aTB with less than 1 month of treatment and aTB after completing treatment. Peripheral blood mononuclear cells were stimulated with ESAT-6/CFP-10 or PPD antigens and acquired for flow cytometry after labelling with conjugated antibodies against CD3, CD4, CD8, CD27, IFN-γ, TNF-α, CD38, HLA-DR, and Ki-67. Conventional and multiparametric analyses were done with FlowJo and OMIQ, respectively. Results: The expression of CD27, CD38, HLA-DR and Ki-67 markers was analyzed in CD4+ T-cells producing IFN-γ and/or TNF-α cytokines after ESAT-6/CFP-10 or PPD stimulation. Within antigen-responsive CD4+ T-cells, CD27− and CD38+ (ESAT-6/CFP-10-specific), and HLA-DR+ and Ki-67+ (PPD- and ESAT-6/CFP-10-specific) populations were significantly increased in aTB compared to LTBI. Ki-67 demonstrated the best discriminative performance as evaluated by ROC analyses (AUC > 0.9 after PPD stimulation). Data also points to a significant change in the expression of CD38 (ESAT-6/CFP-10-specific) and Ki-67 (PPD- and ESAT-6/CFP-10-specific) after ending the anti-TB treatment regimen. Furthermore, ratio based on the CD27 median fluorescence intensity in CD4+ T-cells over Mtb-specific CD4+ T-cells showed a positive association with aTB over LTBI (ESAT-6/CFP-10-specific). Additionally, multiparametric FlowSOM analyses revealed an increase in CD27 cell clusters and a decrease in HLA-DR cell clusters within Mtb-specific populations after the end of treatment. Conclusion: Our study independently confirms that CD27−, CD38+, HLA-DR+ and Ki-67+ populations on Mtb-specific CD4+ T-cells are increased during active TB disease. Multiparametric analyses unbiasedly identify clusters based on CD27 or HLA-DR whose abundance can be related to treatment efficacy. Further studies are necessary to pinpoint the convergence between conventional and multiparametric approaches., This research was supported by a grant from the Instituto de Salud Carlos III (PI18/00411, PI19/01408 and CP20/00070), integrated in the Plan Nacional de I + D + I and cofunded by the ISCIII Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER); a grant from the Sociedad Española de Neumología y Cirugía Torácica (project 25/2016; SEPAR; Barcelona, Spain); and from the European Union’s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement no. 823854 (INNOVA4TB). JD and IL are researchers from the Miguel Servet programme. AS-M is supported by a Juan Rodés (JR18/00022) postdoctoral fellowship from ISCIII.